文章预览
三代测序探索者每周文献精选 (09.09-09.22 ) 01 Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2 杂志:Signal transduction and targeted therapy(IF=40.8) 发表时间:2024.9.18 第一作者:Miao Zhu(Center for Emerging Infectious Diseases, Wuhan Institute of Virology) 通讯作者:Wuxiang Guan(Center for Emerging Infectious Diseases, Wuhan Institute of Virology) 原文链接:https://www.nature.com/articles/s41392-024-01956-4 Fig1.SARS-CoV-2 infection decreases ACTN4 expression in an epitranscriptomic manner. 亮点: In the current study, the interplay between the host factors and viral proteins were analyzed by combined nanopore high-throughput sequencing and second-generation sequencing. The host factor ACTN4 was found to interact with viral RdRp, which impeded viral replication. Notably, two ACTN4 agonists were capable of inhibiting the replication of various SARS-CoV-2 strains both in vitro and in vivo. The results show
………………………………